Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials

Background: Virtual reality-based therapy (VRBT) is a novel therapeutic approach to be used in women with fibromyalgia syndrome (FMS). The aim of our study is to assess the effect of VRBT to reduce the impact of FMS in outcomes such as pain, dynamic balance, aerobic capacity, fatigue, quality of lif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irene Cortés-Pérez, Noelia Zagalaz-Anula, María del Rocío Ibancos-Losada, Francisco Antonio Nieto-Escámez, Esteban Obrero-Gaitán, María Catalina Osuna-Pérez
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/232106c072854e5da1983b7db4e82fa8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:232106c072854e5da1983b7db4e82fa8
record_format dspace
spelling oai:doaj.org-article:232106c072854e5da1983b7db4e82fa82021-11-25T18:07:41ZVirtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials10.3390/jpm111111672075-4426https://doaj.org/article/232106c072854e5da1983b7db4e82fa82021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1167https://doaj.org/toc/2075-4426Background: Virtual reality-based therapy (VRBT) is a novel therapeutic approach to be used in women with fibromyalgia syndrome (FMS). The aim of our study is to assess the effect of VRBT to reduce the impact of FMS in outcomes such as pain, dynamic balance, aerobic capacity, fatigue, quality of life (QoL), anxiety and depression. Methods: Systematic review with meta-analysis was conducted from a bibliographic search in PubMed, Scopus, PEDro, Web of Science and CINAHL until April 2021 in accordance with PRISMA guidelines. We included randomized controlled trials (RCTs) that compare VRBT versus others to assess the mentioned outcomes in women with FMS. Effect size was calculated with standardized mean difference (SMD) and its 95% confidence interval (95% CI). Results: Eleven RCTs involving 535 women with FMS were included. Using the PEDro scale, the mean methodological quality of the included studies was moderate (6.63 ± 0.51). Our findings showed an effect of VRBT on the impact of FMS (SMD −0.62, 95% CI −0.93 to −0.31); pain (SMD −0.45, 95% CI −0.69 to −0.21); dynamic balance (SMD −0.76, 95% CI −1.12 to −0.39); aerobic capacity (SMD 0.32, 95% CI 0.004 to 0.63); fatigue (SMD −0.58, 95% CI −1.02 to −0.14); QoL (SMD 0.55, 95% CI 0.3 to 0.81); anxiety (SMD −0.47, 95% CI −0.91 to −0.03) and depression (SMD −0.46, 95% CI −0.76 to −0.16). Conclusions: VRBT is an effective therapy that reduces the impact of FMS, pain, fatigue, anxiety and depression and increases dynamic balance, aerobic capacity and quality of life in women with FMS. In addition, VRBT in combination with CTBTE showed a large effect in reducing the impact of FMS and fatigue and increasing QoL in these women.Irene Cortés-PérezNoelia Zagalaz-AnulaMaría del Rocío Ibancos-LosadaFrancisco Antonio Nieto-EscámezEsteban Obrero-GaitánMaría Catalina Osuna-PérezMDPI AGarticlefibromyalgiavirtual realityphysiotherapypainfatiguequality of lifeMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1167, p 1167 (2021)
institution DOAJ
collection DOAJ
language EN
topic fibromyalgia
virtual reality
physiotherapy
pain
fatigue
quality of life
Medicine
R
spellingShingle fibromyalgia
virtual reality
physiotherapy
pain
fatigue
quality of life
Medicine
R
Irene Cortés-Pérez
Noelia Zagalaz-Anula
María del Rocío Ibancos-Losada
Francisco Antonio Nieto-Escámez
Esteban Obrero-Gaitán
María Catalina Osuna-Pérez
Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials
description Background: Virtual reality-based therapy (VRBT) is a novel therapeutic approach to be used in women with fibromyalgia syndrome (FMS). The aim of our study is to assess the effect of VRBT to reduce the impact of FMS in outcomes such as pain, dynamic balance, aerobic capacity, fatigue, quality of life (QoL), anxiety and depression. Methods: Systematic review with meta-analysis was conducted from a bibliographic search in PubMed, Scopus, PEDro, Web of Science and CINAHL until April 2021 in accordance with PRISMA guidelines. We included randomized controlled trials (RCTs) that compare VRBT versus others to assess the mentioned outcomes in women with FMS. Effect size was calculated with standardized mean difference (SMD) and its 95% confidence interval (95% CI). Results: Eleven RCTs involving 535 women with FMS were included. Using the PEDro scale, the mean methodological quality of the included studies was moderate (6.63 ± 0.51). Our findings showed an effect of VRBT on the impact of FMS (SMD −0.62, 95% CI −0.93 to −0.31); pain (SMD −0.45, 95% CI −0.69 to −0.21); dynamic balance (SMD −0.76, 95% CI −1.12 to −0.39); aerobic capacity (SMD 0.32, 95% CI 0.004 to 0.63); fatigue (SMD −0.58, 95% CI −1.02 to −0.14); QoL (SMD 0.55, 95% CI 0.3 to 0.81); anxiety (SMD −0.47, 95% CI −0.91 to −0.03) and depression (SMD −0.46, 95% CI −0.76 to −0.16). Conclusions: VRBT is an effective therapy that reduces the impact of FMS, pain, fatigue, anxiety and depression and increases dynamic balance, aerobic capacity and quality of life in women with FMS. In addition, VRBT in combination with CTBTE showed a large effect in reducing the impact of FMS and fatigue and increasing QoL in these women.
format article
author Irene Cortés-Pérez
Noelia Zagalaz-Anula
María del Rocío Ibancos-Losada
Francisco Antonio Nieto-Escámez
Esteban Obrero-Gaitán
María Catalina Osuna-Pérez
author_facet Irene Cortés-Pérez
Noelia Zagalaz-Anula
María del Rocío Ibancos-Losada
Francisco Antonio Nieto-Escámez
Esteban Obrero-Gaitán
María Catalina Osuna-Pérez
author_sort Irene Cortés-Pérez
title Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials
title_short Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials
title_full Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials
title_fullStr Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials
title_sort virtual reality-based therapy reduces the disabling impact of fibromyalgia syndrome in women: systematic review with meta-analysis of randomized controlled trials
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/232106c072854e5da1983b7db4e82fa8
work_keys_str_mv AT irenecortesperez virtualrealitybasedtherapyreducesthedisablingimpactoffibromyalgiasyndromeinwomensystematicreviewwithmetaanalysisofrandomizedcontrolledtrials
AT noeliazagalazanula virtualrealitybasedtherapyreducesthedisablingimpactoffibromyalgiasyndromeinwomensystematicreviewwithmetaanalysisofrandomizedcontrolledtrials
AT mariadelrocioibancoslosada virtualrealitybasedtherapyreducesthedisablingimpactoffibromyalgiasyndromeinwomensystematicreviewwithmetaanalysisofrandomizedcontrolledtrials
AT franciscoantonionietoescamez virtualrealitybasedtherapyreducesthedisablingimpactoffibromyalgiasyndromeinwomensystematicreviewwithmetaanalysisofrandomizedcontrolledtrials
AT estebanobrerogaitan virtualrealitybasedtherapyreducesthedisablingimpactoffibromyalgiasyndromeinwomensystematicreviewwithmetaanalysisofrandomizedcontrolledtrials
AT mariacatalinaosunaperez virtualrealitybasedtherapyreducesthedisablingimpactoffibromyalgiasyndromeinwomensystematicreviewwithmetaanalysisofrandomizedcontrolledtrials
_version_ 1718411605720432640